Company / R&D per Share
Lucid Diagnostics Inc. R&D per Share History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.17
FY2024
5-year range
$0.17 / $0.39
FY2021-FY2024
Trend
-38.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.27 to $0.17 over the past 2 years.
Based on SEC 10-K filings.
0.17 in FY2024 with a 3-year CAGR of -23.7%.
Declined from $0.27 to $0.17 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -23.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, r&d per share decreased 38.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.17 | -38.3% |
| FY2023 | $0.28 | +4.4% |
| FY2022 | $0.27 | -31.0% |
| FY2021 | $0.39 | - |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 24, 2026